is the guarantor of this work and, as such, had full access to all the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis
In clinical trials, patients on tirzepatide 15mg lost an average of 20.2% of body weight at 72 weeks
People who are looking for profound weight loss will likely be disappointed. Since patients often need to stay on GLP-1 medications indefinitely to maintain results, liraglutides daily injection may also prove to be a major hurdle for long-term success
One of the biggest milestones
The medication needs time to build in your system, and therapeutic doses are not reached until weeks 9 to 17 depending on the titration schedule
They both lower the risk for heart-related complications, but differ in other approved uses and populations, side effects, dosage forms and costs